Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Oct 10, 2021 3:07pm
118 Views
Post# 33993678

RE:What are we waiting for

RE:What are we waiting forMore than science to consider here ,are they going to replace one narcotic with another ? Dronabinal is the  narcotic in REDUVO  and studies have been done for years on this topic, nothing new here.Burnt investors  have nothing to do with the lack of interest volume, the big players don't care, the Doctors don't care, no results , no sure thing , nothing has been proven, burnt investors not paid bashers that is why the volume .If Guy is so sure about all the so called science then why is he selling shares for .17 and warrants at .21 till 2023 ? Looks to me like a better get money where we can move before we run out of money.How is the share price of a company ever going to go up if the CEO is giving warrants at .21 for 2 years , till 2023.That tells me perhaps he is not that sure of his so called science or if another opioid that Canada  banded in 1985 will now be approved. 
<< Previous
Bullboard Posts
Next >>